When a bioprocess shifts, can your team trace the evidence behind what happens next?

Marc Smith of IDBS follows a CMC investigation from multi-batch data and risk assessment through DoE and process updates.

📅 Nov 13, 16:30 GMT
🔗 eu1.hubs.ly/H0zGzDT0

Generating more antibody sequences is only valuable if you can identify which candidates should progress.

Brady Wu of Biointron explores how experimental data can reveal candidate liabilities and inform the next AI design cycle.

📅 Nov 19, 16:00 GMT
🔗 eu1.hubs.ly/H0zvM8D0

Robotic systems can generate data faster than scientists can review it. Where should automation go next?

Michael Gallagher of Johnson & Johnson and Ada Yee of Genedata explore automated analysis and closed-loop discovery.

📅 Dec 1, 16:00 GMT
🔗 eu1.hubs.ly/H0zvBmj0

Join this TechTalk to explore how the Zetasizer Core combines dynamic light scattering, static light scattering, and differential scanning fluorimetry to deliver a more comprehensive picture of biologics stability.

👉 Register now to secure your place: eu1.hubs.ly/H0zFWVy0

Coming up next week: Advance quantitative and low-dose 4D-STEM.

Prof. Knut Müller-Caspary of LMU Munich and Quantum Detectors explore Timepix4, ferroelectric PZT, beam-sensitive MOFs and event-driven detection.

📅 Nov 11, 14:00 GMT
🔗 eu1.hubs.ly/H0zs2Qn0

🎥 Now available on demand

Dr. Christian Reece of Rice University explores operando DRIFTS, transient catalyst behavior, and more accessible instrumentation in this webinar with Specac Ltd.

🔗 eu1.hubs.ly/H0zvxXF0

Finding a promising cell is valuable. Recovering it alive could unlock what happens next.

Dr. Sarah Taylor of Lightcast explores functional single-cell assays and live-cell recovery for downstream study.

📅 Nov 18, 15:00 GMT
🔗 eu1.hubs.ly/H0zkc300

From patient-derived tumor organoids to a first-in-class drug candidate.

Don’t miss Prof. Dr. Christophe Deben with @tecan sharing the journey from screening to a candidate progressing towards the clinic.

Secure your place: eu1.hubs.ly/H0zf0XV0

Discover how stronger traceability can keep scientific evidence, decisions and rationale connected across development, making Module 3 preparation easier to interpret and defend. 
 
Watch yesterday's webinar with @IDBSsoftware on demand: eu1.hubs.ly/H0zzW-C0

What do bitterness, colour and VDKs reveal about the quality of your beer?

Discover how filtration and UV-Vis can help brewers monitor these critical parameters, improve clarity and minimize contamination risks.

Secure your place: eu1.hubs.ly/H0zdqrn0

@thermofisher

Explore the technologies and expert insights helping researchers improve scalability, analytical confidence, and performance across the oligonucleotide workflow.

Read and explore the feature: eu1.hubs.ly/H0z0Fxd0

From atomic-scale ferroelectrics to beam-sensitive MOFs.

Prof. Knut Müller-Caspary of LMU Munich and Quantum Detectors explore how event-driven 4D-STEM can support quantitative analysis and low-dose imaging.

📅 Nov 11, 14:00 GMT
🔗 eu1.hubs.ly/H0zs1T_0

Model-Informed Drug Development (MIDD) is helping clinical teams bring together safety, pharmacokinetic/pharmacodynamic, biomarker and efficacy data to optimize dose decisions earlier.

Register now to learn more: eu1.hubs.ly/H0z0BC_0

Explore how connected CMC knowledge can strengthen traceability, preserve scientific rationale and support Module 3 preparation: eu1.hubs.ly/H0ztLwb0

Great beer starts with consistency.

Join Dr. Jennifer Empey-Kohl and Rebecca A. Lucht from @thermofisher to explore how filtration and UV-Vis analysis can support clarity, quality and consistency across the brewing process.

Register now: eu1.hubs.ly/H0zdqKP0

Explore how industrial-scale protein production, flexible expression workflows and structured AI-ready data can help teams validate more candidates, accelerate DBTL cycles and unlock greater value from their discovery programs.

Last chance to register: eu1.hubs.ly/H0zhbGZ0

Explore our latest editorial feature for insights into electron microscopy, 4D-STEM, infrared and Raman microscopy, and the future of materials characterization.

Explore the feature: eu1.hubs.ly/H0z0CJn0

🧬 What will it take to move MRD testing in liquid biopsy towards wider clinical adoption?

Join our #CLINICAL24 Forum to explore validation, reproducibility, standardization and best practice.

📅 Nov 5 | 16:00 GMT
🔗eu1.hubs.ly/H0znHjh0

#MRD #LiquidBiopsy

The next chapter of cell line development is here.

Explore the advanced analytical technologies that are helping researchers generate deeper insight, scale with confidence and make more informed decisions across the workflow.

Download your free copy:
eu1.hubs.ly/H0z0CcM0

AI can design an antibody sequence, but can it produce a viable therapeutic candidate?

Brady Wu, PhD, of Biointron explores how rapid wet-lab validation and standardized data can strengthen AI-driven antibody discovery.

📅 Nov 19, 16:00 GMT
🔗 eu1.hubs.ly/H0znMBn0